Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Lamnet vs Lamictal 100mg Tablets in Healthy Male Pakistani Subjects
NCT04938856Phase 1Completed
- Sponsor
- University of Karachi
- Start
- Sep 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lamotrigine in epilepsy (2 arms), sponsored by University of Karachi. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve and 1 more. Started Sep 2020; status: completed.
02
Drugs
lamotrigine
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT04938856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04938856.